A clinical trial to study the effect of two drugs, Rasnadidashmool kwatha and Erandadi kwath in patients of Amavata (Rheumatoid Arthritis)

INTERVENTION: Intervention1: Rasnadidashmool Kwath: 48gm BD in kwath form for 35 days Control Intervention1: Erandadi Kwath: 48gm BD in kwath form for 35 days CONDITION: Patients of Amavata without any other co‐existing disease PRIMARY OUTCOME: Symptomatic relief in cardinal signs and symptoms of patients ; Improvement in DAS‐28 Score‐‐‐‐‐‐Timepoint: 35 days SECONDARY OUTCOME: Subjective improvement in the patients will be assessed by adopting suitable scoring pattern. ; Decrease in elevated levels of CRP,ESR,RA factor and other biochemical parameters. ; Assessment of grip strength and walking time by suitable method.‐‐‐‐‐‐Timepoint: 35 days INCLUSION CRITERIA: 1‐Amavata of any dosha Anubandha 2‐Diagnosis of Amavata as per symptoms described in Madhav Nidana 3‐Diagnosis of Rheumatoid arthritis as per ACR criteria